Jamal Jones

FDA

2 appearances in the program

Sessions & presentations

PS43: From FDA Draft Guidance to Practice: Credible and Fit-for-Purpose AI in Clinical Drug Development and Post-Market Surveillance

Presentation: From FDA Draft Guidance to Practice: Credible and Fit-for-Purpose AI in Clinical Drug Development and Post-Market Surveillance: Panel Discussion

Parallel · Fri, Sep 18 , 1:30 PM

Panelist

PS43: From FDA Draft Guidance to Practice: Credible and Fit-for-Purpose AI in Clinical Drug Development and Post-Market Surveillance

Presentation: Placeholder for Dr. Jamal T. Jones

Parallel · Fri, Sep 18 , 1:30 PM

Presenting Author